Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
MBX
MBX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MBX News
Analyst Target Prices Indicate Potential for Pharmaceuticals ETF
Jan 29 2026
NASDAQ.COM
MBX Biosciences Advances Obesity Drug Development with Strong Cash Position
Jan 11 2026
Globenewswire
MBX Biosciences Updates on 2026 Clinical Progress and Strong Cash Position
Jan 11 2026
Newsfilter
Monte Rosa Therapeutics Shares Surge 45.2% After Phase 1 Data Release
Jan 07 2026
Benzinga
Microbix Launches First Recombinant Antigen Product for COVID-19 Testing
Jan 07 2026
Yahoo Finance
MBX Biosciences to Present Novel Therapies at 44th J.P. Morgan Healthcare Conference
Dec 15 2025
Newsfilter
Microbix Biosystems to Release Q4 2025 Financial Results on December 18, 2025
Dec 11 2025
Globenewswire
Microbix Biosystems to Release Q4 2025 Financial Results on December 18, 2025
Dec 11 2025
Newsfilter
Microbix Launches QAPs for H3N2 Flu Testing
Dec 10 2025
Globenewswire
Microbix Launches QAPs for H3N2 Flu Testing
Dec 10 2025
Newsfilter
Microbix Initiates NCIB to Repurchase Up to 6.95 Million Shares
Dec 04 2025
Globenewswire
Microbix Partners with Seegene to Enhance HPV Testing Quality
Dec 03 2025
Globenewswire
Microbix Partners with Seegene to Enhance HPV Testing Quality
Dec 03 2025
Newsfilter
Guggenheim Reiterates Buy Rating on MBX Biosciences, Adjusts Price Target to $77
Nov 10 2025
Benzinga
Analyst Starts Coverage on Twist Bioscience with Optimism; Check Out Tuesday's Top 5 Initiations
Nov 04 2025
Benzinga
Top Analysts Recommend 3 Best Stocks to Purchase Now, 11/4/2025
Nov 04 2025
TipRanks
Show More News
